Donaldn Forthal News Today

Study: Antibody combo offers benefit in mild, moderate COVID-19 By (0) Monoclonal antibodies may provide some benefit for those with mild to moderate COVID-19, a new study has found. File Photo by Bill Greenblatt/UPI | License Photo Jan. 21 (UPI) -- Two antibody drugs significantly reduce the amount of COVID-19 in people with mild or moderate symptoms, a study published Thursday by JAMA found. The drugs, called monoclonal antibodies, are laboratory-made proteins designed to mimic the immune s...